Skip to main content
TipRanks
Go Ultimate75% OFF

Christopher Maxwell Fullerton Insider Profile

4 Followers

Christopher Maxwell Fullerton, Director at XTEK Limited, holds 254.06K shares in XTEK Limited (Ticker: AU:HCL), holds 0.00 shares in Life (Ticker: CORFF), holds 1.07M shares in Paradigm Biopharmaceuticals (Ticker: PBIGF).

Christopher Maxwell Fullerton's Trading History

PBIGF
Paradigm Biopharmaceuticals
Nov 19, 2019DirectorInformative Buy301.05K$11.77K
NEUP
Neuphoria Therapeutics
―Director―$9.45M
EGL
Environmental Group Limited
―Director―AU$810.44K
CORFF
Life
―――$0.00
HCL
XTEK Limited
―Director―AU$23.12K

You May Also Like

Christopher Maxwell Fullerton insider profile FAQ

What is the percentage of profitable transactions made by Christopher Maxwell Fullerton?
The percentage of profitable transactions made by Christopher Maxwell Fullerton is 100%.
What is the average return per transaction made by Christopher Maxwell Fullerton?
The average return per transaction made by Christopher Maxwell Fullerton is 128.40%.
What stocks does Christopher Maxwell Fullerton hold?
Christopher Maxwell Fullerton holds: AU:HCL, CORFF, PBIGF, AU:EGL, NEUP stocks.
What was Christopher Maxwell Fullerton's most profitable transaction?
Christopher Maxwell Fullerton’s most profitable transaction was an Informative Buy of PBIGF stock on July 3, 2019. The return on the trade was 136.60%.
What is Christopher Maxwell Fullerton's role in XTEK Limited?
Christopher Maxwell Fullerton's role in XTEK Limited is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.